Rani Khatib1,2, Jan Keenan3. 1. Medicines Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2. Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, UK. 3. Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, UK.
We read with great interest a recent article entitled ‘Secondary prevention and
cardiovascular care across Europe: a survey of European Society of Cardiology members’ views’.[1] In this survey of 479 healthcare professionals from eight countries, the main
barriers identified were lack of available cardiac rehabilitation programmes and
long-term follow-up, patients’ disease perception and professional attitudes towards
prevention. Barriers to prevention varied based on the survey participants’ country of
origin; however, there was consensus across all countries on the three most important
strategies to improve prevention, namely multidisciplinary interventions, patient
education and introducing performance measures.[1] In the UK, shortcomings in the delivery of secondary prevention programmes have
also been linked with suboptimal outcomes for patients with cardiovascular disease
(CVD), and recently a group of multidisciplinary team (MDT) members working in secondary
prevention in primary and secondary care settings has developed a UK consensus on
optimising CVD secondary prevention care.[2]As co-authors of the UK consensus statement, we were mindful that there is not a uniform,
one-size-fits-all model of CVD secondary prevention care, and that within our National
Health Service (NHS), the roles undertaken by different MDT members can vary depending
on the skillsets and healthcare resources available locally. Within the typical
management pathway for post-myocardial infarction follow-up, numerous opportunities for
MDT members to deliver secondary prevention care from the time of initial presentation
and hospitalisation through to long-term post-discharge follow-up were identified and
outlined. In addition, a range of best practice models from across the UK that are
currently achieving success in reducing cardiovascular risk were described and endorsed
with a view to being adopted or adapted elsewhere. These included a pharmacist-led,
hospital-based post-myocardial infarction medicines optimisation programme,[3] a nurse-led integrated community-based CVD prevention programme and a GP-led
one-stop heart failure diagnosis and management clinic model for primary care. All of
these models provide practical examples of ways that different healthcare professionals
involved in delivering MDT care can work together to improve patients’ outcomes in CVD,
for example through recognising and addressing poor adherence to cardioprotective medication.[4],[5]The data analysis from Fitzsimons et al.[1] underlines that secondary prevention is often suboptimal across the European
countries included in the European Society of Cardiology (ESC) survey. Given that MDT
members are central to delivering CVD secondary care, it is understandable that an
Association of Cardiovascular Nursing and Allied Professions (ACNAP) task force is
currently examining ways to support greater collaboration between allied professions and
to address uncertainties about the roles that different MDT members can play in CVD
secondary prevention. We suggest that the UK consensus statement (which is available
online as an open-access publication) may provide insights and practical guidance which
are of interest to cardiovascular nurses and MDT members working in CVD secondary care
across Europe.